University of Oxford Archives

News and Trends 17 Apr 2023

Ghana becomes first country to approve University of Oxford malaria vaccine

Ghana has granted full national licensure for the University of Oxford’s R21/Matrix-M malaria vaccine, marking the first regulatory clearance for the vaccine for use in any country. Developed by the…

April 17, 2023 - 4 minutesmins - By Willow Shah-Neville

News and Trends 9 Sep 2022

Fight against malaria boosted by findings from a vaccine trial showing high efficacy

Hope that malaria could be eradicated forever has been given a boost after new findings from a vaccine trial showed a high-rate of efficacy. Researchers from the University of Oxford…

September 9, 2022 - 4 minutesmins - By Liza Laws

News and Trends 18 Jul 2022

Oxford Science Enterprises raises £250M

Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses via its partnership with the University of Oxford, has raised a further £250 million…

July 18, 2022 - 4 minutesmins - By Jim Cornall

News and Trends 9 Feb 2021

EMA Green Light Sends Oxford Covid-19 Vaccine Into Turbulent Market

As AstraZeneca and the University of Oxford’s Covid-19 vaccine debuts in the EU market this month, supply bottlenecks, viral variants, and political squabbles demonstrate that the quest to develop and…

February 9, 2021 - 6 minutesmins - By Kostas Vavitsas

News and Trends 26 Nov 2020

AstraZeneca’s Covid-19 Vaccine Proves Its Worth in Phase III

A much anticipated Covid-19 vaccine, developed by the University of Oxford and AstraZeneca, achieved 70% efficacy in phase III interim data. While less effective on paper, it could prove cheaper…

November 26, 2020 - 4 minutesmins - By Kostas Vavitsas

More News! 7 Oct 2019

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

MiroBio has spun out of the University of Oxford with a Series A round of €30M (£27M) to develop treatments for autoimmune diseases that don’t disrupt the immune system as…

October 7, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 24 May 2018

Organs-on-a-Chip for Drug Research in a Range of Diseases Make it to the Market

CN Bio Innovations has globally launched an organ-on-a-chip device that allows scientists to test potential drugs on living human organ models. CN Bio Innovations, an Oxford University spin-out, has launched…

May 24, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 30 Jun 2017

€40M in Series C for a British Biotech Treating Blindness with Gene Therapy

NightstaRx has raised €39.5M that will go towards three clinical programs testing gene therapies for rare diseases that cause blindness. NightstaRx is developing gene therapies for genetic retinal diseases that…

June 30, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 22 Jun 2017

LAB282 Awards Second Funding Round to 5 Academic Projects at Oxford

Evotec and the University of Oxford have announced the academic projects that will receive a financial award to push them towards launching spin-outs. LAB282 is a partnership between the German biotech…

June 22, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Scenic Biotech Genetic Off Switch Cancer Rare Disease

News and Trends 5 Jun 2017

New Dutch Biotech Gets Funding to Find Genetic Off Switches

Scenic Biotech is applying a technology to identify first-in-class therapeutic targets that has secured it €6.5M in Series A. Scenic Biotech, founded in Amsterdam just this year, has raised €6.5M to…

June 5, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Mission Therapeutics Parkinsons research grant

News and Trends 11 Apr 2017

New Grant to Advance a Whole New Treatment Against Parkinson’s in the UK

Mission Therapeutics has received a grant to support the development of a novel approach to treating Parkinson's that is attracting top partners worldwide. Right on time for World Parkinson's Day today, Mission…

April 11, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 11 Mar 2017

You Can Watch Fleming’s Original Penicillin Culture in Oxford!

The Museum of the History of Science in Oxford is hosting an exhibition on the history of penicillin and the current challenges of antibiotic resistance featuring the first culture used…

March 11, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

HIV vaccine University Oxford IrsiCaixa AIDS

News and Trends 3 Mar 2017

An HIV Vaccine Eliminates the Virus in a Patient for 7 Months

An HIV vaccine developed at the University of Oxford has kept 5 out of 15 patients completely free of HIV. One of the patients has already been clear for 7 months. AIDS…

March 3, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 30 Jan 2017

Novo Nordisk will open a €135M Diabetes R&D Center at Oxford University

A new research center funded by Novo Nordisk will foster collaborations between its staff and researchers from the University of Oxford. Novo Nordisk and the University of Oxford have announced…

January 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Screenshot 2016 12 19 at 4.24.40 PM e1482161199959

News and Trends 21 Dec 2016

Can partnerships between Biotechs and Academia be the Key to Success?

We had the opportunity to hear the story behind the successful Evotec by Thomas Hanke, Executive VP, who gave plenty of advice for biotech companies seeking to grow. One of the biggest…

December 21, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Nov 2016

Evotec chooses Oxford as Proving Ground for Academia-Industry Bridge

The German CRO has struck a deal with the University of Oxford to test a model framework for bringing academic research to the clinic faster. Evotec started out as a…

November 10, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 7 Nov 2016

Results from 45% of Clinical Trials are kept Secret

A new transparency study has identified Sanofi, Novartis and GSK as the companies that keep the most clinical trial results unreported. TrialsTracker is a tool developed at the University of Oxford…

November 7, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 4 Oct 2016

One Step Closer to an HIV Cure That Can Eliminate the Latent Virus

HIV has completely disappeared from the blood of a patient in clinical trials. The new HIV treatment that can target the virus even in its dormant state by activating latent infected cells and…

October 4, 2016 - 3 minutesmins - By Clara Rodríguez Fernández

sleep homeostasis sandman channel oxford cncb

News and Trends 8 Aug 2016

The Brain’s Sleep Switch was just discovered, zZz …

Researchers from the University of Oxford have discovered how certain neurons control when we go to sleep. The biology behind it involves an ion channel that reacts to the 'happy…

August 8, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 13 Jun 2016

Immunotherapy reaches Breakthrough in eliminating HIV

Immunocore has published key results for its new preclinical candidate for HIV, ImmTAV. This TCR-based immunotherapy has succeeded in targeting T-cells where HIV infection often 'hides' from drugs. Just after…

June 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Find new scientific partnerships. Create a free IN-PART account

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inova, the leading platform for biopharma partnering